<DOC>
	<DOCNO>NCT02285686</DOCNO>
	<brief_summary>Troponins sensitive specific marker cardiac injury . Critically ill patient frequently elevate troponins . In population , distinguish patient elevate troponins myocardial infarction difficult . However , troponin elevation seem associate increased risk death . The optimal treatment patient type 2 myocardial infarction non ischemia relate troponin elevation critical illness unclear . There trial ICU set guide management . This study 1-month pilot cohort study troponin screen 4 Ontario intensive care unit . The objective pilot study evaluate ability perform large study , determine prevalence , incidence risk factor elevate troponin value , patient elevate troponin value treat baseline , incidence myocardial infarction critically ill patient . Knowing prognostic impact condition understand current management thereafter guide researcher clinician importance carefully evaluate potential risk-modifying therapy .</brief_summary>
	<brief_title>Prognostic Value Elevated Troponins Critical Illness Study : A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<criteria>All adult patient admit participate ICUs study site study enrollment period eligible . Patients admit die discharge within 12 hour Patients readmitted ICU index ICU enrolment month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>troponin</keyword>
	<keyword>biomarkers</keyword>
	<keyword>myocardial infarction</keyword>
	<keyword>critical illness</keyword>
</DOC>